Angiotensin‐converting enzyme II expression and its implication in the association between COVID‐19 and allergic rhinitis
Angiotensin‐converting enzyme II expression and its implication in the association between COVID‐19 and allergic rhinitis
In conclusion, for the first time, we provide the evidence that AR comorbidity may not have significant modifying effect on the development and expression of COVID‐19. ACE2 expression is not altered in AR patients. ACE2 gene expression in airways is regulated, at least in part, by the counter effect of type 2 and IFN inflammation.